| Primary |
| Drug Use For Unknown Indication |
25.5% |
| Prophylaxis |
11.0% |
| Product Used For Unknown Indication |
9.7% |
| Pneumonia |
6.2% |
| Urinary Tract Infection |
5.2% |
| Infection |
4.1% |
| Infection Prophylaxis |
4.1% |
| Anaesthesia |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Pain |
3.4% |
| Eye Infection |
3.1% |
| Antibiotic Prophylaxis |
2.8% |
| Antibiotic Therapy |
2.8% |
| Hypertension |
2.4% |
| Premedication |
2.4% |
| Preoperative Care |
2.4% |
| Peritonsillar Abscess |
2.1% |
| Upper Respiratory Tract Infection |
2.1% |
| Essential Hypertension |
1.7% |
| Vitamin Supplementation |
1.7% |
|
| Vomiting |
11.5% |
| Urticaria |
8.8% |
| Pharmaceutical Product Complaint |
8.0% |
| Visual Disturbance |
8.0% |
| Dyspnoea |
7.1% |
| Tachycardia |
7.1% |
| Anaphylactic Shock |
5.3% |
| Product Quality Issue |
5.3% |
| Rash |
5.3% |
| Hypotension |
4.4% |
| Cardiac Arrest |
3.5% |
| Pyrexia |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Circulatory Collapse |
2.7% |
| General Physical Health Deterioration |
2.7% |
| Incorrect Route Of Drug Administration |
2.7% |
| Laryngeal Oedema |
2.7% |
| Oedema Peripheral |
2.7% |
| Rash Pruritic |
2.7% |
| Type I Hypersensitivity |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
18.8% |
| Drug Use For Unknown Indication |
17.0% |
| Antibiotic Therapy |
7.9% |
| Hypertension |
7.4% |
| Bacterial Infection |
6.6% |
| Endocarditis |
5.7% |
| Pain |
4.8% |
| Infection |
3.9% |
| Prophylaxis |
3.9% |
| Hiv Infection |
3.5% |
| Pneumonia |
3.5% |
| Thrombosis Prophylaxis |
3.1% |
| Depression |
2.6% |
| Urinary Tract Infection |
2.2% |
| Cholecystitis |
1.7% |
| Myeloid Leukaemia |
1.7% |
| Urosepsis |
1.7% |
| Epilepsy |
1.3% |
| Essential Hypertension |
1.3% |
| Gastroenteritis |
1.3% |
|
| Cholestatic Liver Injury |
11.8% |
| Rash |
8.8% |
| Renal Failure Acute |
8.8% |
| Toxic Epidermal Necrolysis |
8.8% |
| Drug Interaction |
5.9% |
| Endocarditis |
5.9% |
| Leukocytoclastic Vasculitis |
5.9% |
| Pancytopenia |
5.9% |
| Paraesthesia |
5.9% |
| Abortion Spontaneous |
2.9% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Agranulocytosis |
2.9% |
| Blood Culture Positive |
2.9% |
| Blood Urea Increased |
2.9% |
| Circulatory Collapse |
2.9% |
| Condition Aggravated |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Grand Mal Convulsion |
2.9% |
| Hallucination |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.6% |
| Coronary Artery Bypass |
13.2% |
| Pyrexia |
5.0% |
| Drug Use For Unknown Indication |
4.9% |
| Hiv Infection |
3.4% |
| Aortic Valve Replacement |
3.2% |
| Pain |
3.2% |
| Hypertension |
3.0% |
| Catheterisation Cardiac |
2.5% |
| Hypovitaminosis |
2.4% |
| Prophylaxis |
2.2% |
| Surgery |
2.1% |
| Mitral Valve Replacement |
2.0% |
| Infection Prophylaxis |
1.8% |
| Sepsis |
1.6% |
| Pneumonia |
1.5% |
| Aortic Surgery |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Cardiogenic Shock |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
|
| Injury |
13.0% |
| Anxiety |
11.6% |
| Pain |
10.5% |
| Unevaluable Event |
9.8% |
| Fear |
6.7% |
| Anhedonia |
6.0% |
| Emotional Distress |
5.6% |
| Stress |
4.6% |
| Renal Failure |
3.9% |
| Visual Impairment |
3.9% |
| Pneumonia |
3.2% |
| Renal Impairment |
3.2% |
| Renal Injury |
3.2% |
| Rhabdomyolysis |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
| Death |
2.1% |
| Troponin Increased |
2.1% |
| Depression |
1.8% |
| Multi-organ Failure |
1.8% |
| Nervousness |
1.8% |
|
| Interacting |
| Endocarditis |
25.0% |
| Hypertension |
25.0% |
| Post Procedural Infection |
25.0% |
| Epilepsy |
12.5% |
| Procedural Pain |
12.5% |
|
| Grand Mal Convulsion |
50.0% |
| Drug Interaction |
25.0% |
| Empyema |
25.0% |
|
